Serum infliximab concentrations and body mass index in patients with inflammatory bowel disease.

this study did not confirm that BMI influences IFX concentrations. More studies are needed to explore the impact of BMI on IFX pharmacokinetics and therapeutic efficacy.

Institutions

Publication Details

Journal
PubMed
Published
2025-11-13
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum infliximab concentrations and body mass index in patients with inflammatory bowel disease.

PubMed
Inflammatory Bowel Disease
article

Serum infliximab concentrations and body mass index in patients with inflammatory bowel disease.

article en

Abstract

this study did not confirm that BMI influences IFX concentrations. More studies are needed to explore the impact of BMI on IFX pharmacokinetics and therapeutic efficacy.

PubMedVol. 45(3)
Pontifícia Universidade Católica do Paraná (BR), Universidade Positivo (BR)
Good health and well-being
Openalex Percentile: Top 31%
Inflammatory Bowel Disease
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum infliximab concentrations and body mass index in patients with inflammatory bowel disease. · PubMed (2025) | TGRS Research Map | TGRS